CLINICAL_TRIALS
trial_result
· 2021-05-21
Clinical Trial Update: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) [Phase 2, Phase 3]
Summary
A clinical trial update for CyclASol in dry eye disease across Phase 2 and Phase 3 has completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novaliq GmbH | Conditions: Dry Eye Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-05-21